NCT01109446 is a NA clinical trial of Platelet Rich Plasma in Lateral Epicondylitis, sponsored by University of Aarhus.

Who is sponsoring NCT01109446?

NCT01109446 is sponsored by University of Aarhus.

What drugs are being tested in NCT01109446?

Interventions in NCT01109446: Platelet Rich Plasma, Isotonic Saline Solutions, Triamcinolonacetonid.

What condition does NCT01109446 study?

NCT01109446 studies Lateral Epicondylitis.

Is NCT01109446 still recruiting?

NCT01109446 is currently completed. Last updated 13 February 2012.

Last reviewed 2012-02-13 · How we verify

NCT01109446

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Lateral Epicondylitis. Platelet Rich Plasma vs. Steroid vs. Saline Solution

Completed NA Last updated 13 February 2012

What this trial tests

NA trial testing Platelet Rich Plasma in Lateral Epicondylitis in 60 participants. Completed in 1 October 2011.

Timeline

1 January 2009

Primary endpoint
1 October 2011

1 October 2011

Quick facts

Lead sponsor	University of Aarhus
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	1 January 2009
Primary completion	1 October 2011
Estimated completion	1 October 2011
Sites	1 location across Denmark

Drugs / interventions tested

Platelet Rich Plasma — full drug profile →
Isotonic Saline Solutions
Triamcinolonacetonid — full drug profile →

Conditions studied

Lateral Epicondylitis — all drugs for Lateral Epicondylitis →

Sponsor

University of Aarhus

Who can join

18 and older, any sex, with Lateral Epicondylitis. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Changes in pain as a continuous outcome measure. Using The Patient-Rated Tennis Elbow Evaluation (PRTEE) questionaire.
Time frame: first day, 1 months, 3 months, 6 months, 12 months.
We use the PRTEE questionaire, which is validated for tennis elbow.

Sponsor's own description

We wish to address the efficacy and safety of Platelet Rich Plasma (blood platelets), a new treatment for lateral epicondylitis (tennis elbow) and compare this new treatment to either injection with steroid or saline solution. All injections are guided by ultrasonography.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain.
Karjalainen TV, Silagy M, O'Bryan E, Johnston RV, et al · · 2021 · cited 19× · PMID 34590307 · DOI 10.1002/14651858.cd010951.pub2

Verify or expand the search:

Other trials of Platelet Rich Plasma

Trials testing the same drug.

NCT07483320 — Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy · NA · not yet recruiting
NCT07329361 — Efficacy and Safety of Intra-articular Injections of Frozen Platelet-Rich Plasma in Patients With Knee Osteoarthritis · NA · recruiting
NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT06810726 — Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroisc · Phase 2 · recruiting
NCT06769074 — Assessment of Platelet Rich Plasma Injection in Managing Female Patients Complaining of Mixed Urinary Incontinence (PRP) · NA · active not recruiting

Other recruiting trials for Lateral Epicondylitis

Currently open trials in the same condition.

NCT07424794 — Mobilization With Movement Verses Cyriax Techniques Among Athletes With Lateral Epicondylitis · NA · recruiting
NCT07365033 — Eccentric Exercise With Blood Flow Restriction vs Resistance Training for Lateral Epicondylitis · NA · recruiting
NCT07342426 — High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis · Phase 4 · recruiting
NCT07410663 — Hyaluronic Acid and Amino Acid Combination Versus Exercise for Chronic Lateral Epicondylitis · active not recruiting
NCT07314840 — Ultrasonographic Examination of Other Enthesitis Sites in Patients With Lateral Epicondylitis · recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01109446 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 13 February 2012

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01109446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing